Nicoya Lifesciences Acquires Applied Photophysics

Nicoya Lifesciences Acquires LSK Technologies

May 2, 2022

Medical Devices

Nicoya Lifesciences has completed the acquisition of University of Toronto spinout LSK Technologies, integrating LSK's high-throughput lab-in-a-box molecular testing platform into Nicoya's digital proteomics and point-of-need testing portfolio. The LSK team will join Nicoya to accelerate product development and expand the combined platform's capabilities for rapid, laboratory-quality molecular and antigen testing.

CACI International Acquires SA Photonics

December 16, 2021

Aerospace & Defense

CACI International has completed the acquisition of SA Photonics, a developer of free-space optical (FSO) communications and LiDAR sensing technologies. The deal expands CACI's photonics engineering and scaled manufacturing capabilities — adding facilities in California and Florida — to serve U.S. government, intelligence, and commercial space (LEO) customers.

Quanterix Corporation Acquires Akoya Biosciences

July 8, 2025

Medical Devices

Quanterix Corporation has completed its acquisition of Akoya Biosciences, combining Quanterix's ultra‑sensitive blood biomarker detection platform with Akoya's spatial biology imaging and reagents. Under the amended merger agreement, Quanterix issued approximately 7.8 million shares and paid about $20 million in cash to Akoya equity holders; the combined business is expected to expand the company's served addressable market and accelerate the path to profitability.

Applied UV Acquires PURO Lighting and LED Supply Co.

December 19, 2022

Medical Devices

Applied UV, Inc. (NASDAQ:AUVI) entered into definitive agreements to acquire PURO Lighting, LLC and LED Supply Co. in a combined transaction valued at approximately $20 million (cash and restricted shares). The deals would roughly double Applied UV's size—adding an estimated $18 million of revenue—and expand its distribution, sales capabilities and access to PURO's strategic relationships (including Acuity Brands) for FDA‑cleared disinfection products.

Optibrium Acquires BioPharmics LLC

August 31, 2023

Software

Optibrium, a Cambridge-based developer of software and AI solutions for small-molecule drug discovery, has acquired BioPharmics LLC to expand its 3D ligand- and structure-based drug design and visualisation capabilities. The acquisition brings BioPharmics' algorithms and products (including ForceGen, Surflex-Dock, eSim and QuanSA) and its founding scientists into Optibrium's StarDrop platform to strengthen 3D modelling, docking and binding-affinity prediction functionality.

MKS Instruments Acquires Photon Control

May 10, 2021

Manufacturing

MKS Instruments agreed to acquire Photon Control Inc. in an all-cash transaction valued at approximately CAD$387 million (enterprise value ~CAD$343 million). The acquisition expands MKS's sensing capabilities—adding optical sensors for temperature and position used in semiconductor wafer fabrication—and is expected to be accretive to non-GAAP net earnings within 12 months, with closing expected in Q3 2021 subject to customary approvals.